HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yonghong Zhang Selected Research

Virus Diseases (Viral Diseases)

1/2020A Novel Scoring System for Prediction of Disease Severity in COVID-19.
1/2020Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.
4/2015Pretreatment serum macrophage inflammatory protein (MIP)-1 levels predict sustained virological responses to re-treatment in patients with chronic hepatitis C virus infection.
11/2011The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yonghong Zhang Research Topics

Disease

120Ischemic Stroke
04/2024 - 04/2009
50Neoplasms (Cancer)
04/2024 - 08/2006
44Stroke (Strokes)
01/2024 - 04/2009
38Infections
10/2023 - 05/2008
34Hypertension (High Blood Pressure)
01/2024 - 08/2008
25Hepatocellular Carcinoma (Hepatoma)
04/2024 - 10/2015
24Inflammation (Inflammations)
02/2023 - 01/2010
12Cognitive Dysfunction
02/2024 - 12/2016
12Cardiovascular Diseases (Cardiovascular Disease)
05/2023 - 09/2007
11Atherosclerosis
01/2023 - 11/2016
10Fibrosis (Cirrhosis)
04/2024 - 10/2013
9COVID-19
01/2023 - 01/2020
8Disease Progression
01/2023 - 02/2007
7Insulin Resistance
01/2023 - 09/2010
7Prehypertension
09/2017 - 10/2008
6Body Weight (Weight, Body)
04/2024 - 01/2006
6Obesity
02/2024 - 08/2011
6Glioma (Gliomas)
12/2023 - 11/2014
6Glioblastoma (Glioblastoma Multiforme)
12/2023 - 08/2006
6Hyperuricemia
07/2020 - 06/2012
6Chronic Hepatitis B
01/2018 - 03/2012
5Burkitt Lymphoma (Burkitt's Lymphoma)
12/2023 - 01/2020
5Carcinogenesis
12/2023 - 09/2015
5Breast Neoplasms (Breast Cancer)
01/2023 - 03/2012
5Diabetes Mellitus
01/2023 - 01/2012
5Hyperglycemia
09/2022 - 06/2015
5Coronary Artery Disease (Coronary Atherosclerosis)
06/2022 - 01/2019
5Lung Neoplasms (Lung Cancer)
01/2021 - 02/2016
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 01/2017
4Pneumonia (Pneumonitis)
01/2023 - 01/2014
4Overweight
01/2022 - 10/2008
4Fatty Liver
01/2021 - 06/2016
4Dyslipidemias (Dyslipidemia)
01/2021 - 01/2014
4Virus Diseases (Viral Diseases)
01/2020 - 11/2011
4HIV Infections (HIV Infection)
01/2019 - 05/2012
4Pulmonary Arterial Hypertension
03/2016 - 03/2014
4Chronic Obstructive Pulmonary Disease (COPD)
03/2015 - 10/2013
3Liver Neoplasms (Liver Cancer)
04/2024 - 10/2018
3Melanoma (Melanoma, Malignant)
02/2024 - 07/2012
3Stomach Neoplasms (Stomach Cancer)
11/2023 - 02/2018
3Liver Diseases (Liver Disease)
07/2023 - 10/2018
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 01/2021
3Edema (Dropsy)
02/2023 - 02/2018
3Acute Lung Injury
01/2023 - 10/2013
3Heart Failure
01/2023 - 01/2018

Drug/Important Bio-Agent (IBA)

84Antihypertensive Agents (Antihypertensives)IBA
01/2024 - 01/2010
49Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2010
32Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2009
22LipidsIBA
04/2024 - 09/2007
22Glucose (Dextrose)FDA LinkGeneric
01/2023 - 11/2009
19C-Reactive ProteinIBA
01/2023 - 08/2008
13DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2010
12MicroRNAs (MicroRNA)IBA
03/2023 - 12/2013
12Triglycerides (Triacylglycerol)IBA
01/2023 - 11/2009
11HDL CholesterolIBA
01/2023 - 11/2009
10InterferonsIBA
01/2021 - 05/2011
9RNA (Ribonucleic Acid)IBA
06/2023 - 05/2008
9Uric Acid (Urate)IBA
01/2021 - 06/2012
8oxidized low density lipoproteinIBA
10/2023 - 01/2014
8InflammasomesIBA
01/2023 - 01/2020
8LDL CholesterolIBA
12/2022 - 06/2009
8Blood Glucose (Blood Sugar)IBA
09/2022 - 08/2008
8CholesterolIBA
01/2022 - 06/2009
8EnzymesIBA
01/2021 - 05/2016
8Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2021 - 08/2017
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2023 - 12/2016
7Messenger RNA (mRNA)IBA
10/2022 - 09/2014
6Chimeric Antigen ReceptorsIBA
11/2023 - 01/2020
6ORALIT (ORS)IBA
11/2022 - 01/2014
5Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2024 - 03/2012
5Apolipoproteins E (ApoE)IBA
01/2024 - 09/2007
5Insulin (Novolin)FDA Link
01/2023 - 08/2008
5HomocysteineIBA
10/2022 - 01/2017
5AntibodiesIBA
01/2021 - 11/2016
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2018 - 10/2013
4Interleukin-6 (Interleukin 6)IBA
05/2023 - 10/2013
4CytokinesIBA
01/2023 - 11/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2021
4IntegrinsIBA
01/2023 - 02/2016
4Indicators and Reagents (Reagents)IBA
01/2023 - 01/2012
4AMP-Activated Protein KinasesIBA
01/2023 - 03/2016
4Therapeutic UsesIBA
01/2022 - 01/2009
4Choline (Choline Chloride)IBA
01/2022 - 04/2018
4AntigensIBA
01/2022 - 01/2016
41-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
12/2021 - 11/2017
4Brain Natriuretic Peptide (Natrecor)FDA Link
12/2020 - 10/2013
4Angiotensin IIIBA
01/2019 - 01/2010
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2024 - 01/2018
3pro-brain natriuretic peptide (1-76)IBA
02/2024 - 12/2017
3Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 01/2019
3Fibrinogen (Factor I)FDA Link
10/2023 - 06/2014
3ChemokinesIBA
10/2023 - 04/2015
3Rheumatoid FactorIBA
05/2023 - 01/2019
3Programmed Cell Death 1 ReceptorIBA
02/2023 - 01/2018
3Immunoglobulins (Immunoglobulin)IBA
02/2023 - 01/2018
3rhodiolosideIBA
01/2023 - 01/2021
3Interleukin-17 (Interleukin 17)IBA
01/2023 - 01/2020

Therapy/Procedure

25Therapeutics
11/2023 - 06/2014
4Aftercare (After-Treatment)
11/2023 - 03/2012
3Drug Therapy (Chemotherapy)
12/2023 - 12/2022